Phase 2 trial of temozolomide using protracted low-dose and whole-brain radiotherapy for nonsmall cell lung cancer and breast cancer patients with brain metastases. (Q46362575)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Phase 2 trial of temozolomide using protracted low-dose and whole-brain radiotherapy for nonsmall cell lung cancer and breast cancer patients with brain metastases.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18798231%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Phase 2 trial of temozolomide using protracted low-dose and whole-brain radiotherapy for nonsmall cell lung cancer and breast cancer patients with brain metastases (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18798231%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

adaptive radiation therapy

0 references

phase II clinical trial

0 references

0 references

1 reference

based on heuristic

inferred from title

Michele Caraglia

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18798231%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Liliana Montella

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18798231%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

author name string

Raffaele Addeo

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18798231%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Carmine De Rosa

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18798231%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Vincenzo Faiola

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18798231%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Luigi Leo

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18798231%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Gregorio Cennamo

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18798231%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Rosario Guarrasi

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18798231%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Bruno Vincenzi

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18798231%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Salvatore Del Prete

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18798231%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

language of work or name

0 references

publication date

1 November 2008

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18798231%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

number of pages

8

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18798231%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

113

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18798231%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18798231%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

2524-2531

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18798231%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Temozolomide and concomitant whole brain radiotherapy in patients with brain metastases: a phase II randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23859

21 January 2018

Phase I trial of temozolomide (CCRG 81045: M&B 39831: NSC 362856)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23859

21 January 2018

Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23859

21 January 2018

Brain neoplasms: epidemiology, diagnosis, and prospects for cost-effective imaging

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23859

7 January 2021

based on heuristic

inferred from DOI database lookup

Brain metastases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23859

7 January 2021

based on heuristic

inferred from DOI database lookup

CNS metastases in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23859

7 January 2021

based on heuristic

inferred from DOI database lookup

Management of Brain Metastases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23859

7 January 2021

based on heuristic

inferred from DOI database lookup

EFNS Guidelines on diagnosis and treatment of brain metastases: report of an EFNS Task Force

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23859

7 January 2021

based on heuristic

inferred from DOI database lookup

Multidisciplinary management of brain metastases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23859

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of temozolomide in heavily pretreated cancer patients with brain metastases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23859

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase II trial of temozolomide for patients with recurrent or progressive brain metastases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23859

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trial of temozolomide and cisplatin followed by whole brain radiotherapy in non-small-cell lung cancer patients with brain metastases: a GLOT-GFPC study.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23859

7 January 2021

based on heuristic

inferred from DOI database lookup

Temozolomide in metastatic breast cancer (MBC): a phase II trial of the National Cancer Institute of Canada - Clinical Trials Group (NCIC-CTG).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23859

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II randomized trial of temozolomide and concurrent radiotherapy in patients with brain metastases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23859

7 January 2021

based on heuristic

inferred from DOI database lookup

Concomitant treatment of brain metastasis with whole brain radiotherapy [WBRT] and temozolomide [TMZ] is active and improves quality of life

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23859

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of temozolomide plus pegylated liposomal doxorubicin in the treatment of brain metastases from solid tumours

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23859

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I study of capecitabine in combination with temozolomide in the treatment of patients with brain metastases from breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23859

7 January 2021

based on heuristic

inferred from DOI database lookup

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23859

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23859

7 January 2021

based on heuristic

inferred from DOI database lookup

Optimal two-stage designs for phase II clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23859

7 January 2021

based on heuristic

inferred from DOI database lookup

Whole-brain radiotherapy in the management of brain metastasis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23859

7 January 2021

based on heuristic

inferred from DOI database lookup

Temozolomide in patients with advanced non-small cell lung cancer with and without brain metastases. a phase II study of the EORTC Lung Cancer Group (08965).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23859

7 January 2021

based on heuristic

inferred from DOI database lookup

Concomitant brain radiotherapy and vinorelbine-ifosfamide-cisplatin chemotherapy in brain metastases of non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23859

7 January 2021

based on heuristic

inferred from DOI database lookup

Metronomic scheduling: the future of chemotherapy?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23859

7 January 2021

based on heuristic

inferred from DOI database lookup

Low-dose metronomic combined with intermittent bolus-dose cyclophosphamide is an effective long-term chemotherapy treatment strategy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23859

7 January 2021

based on heuristic

inferred from DOI database lookup

Continuous low-dose chemotherapy plus inhibition of cyclooxygenase-2 as an antiangiogenic therapy of glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23859

7 January 2021

based on heuristic

inferred from DOI database lookup

Preclinical pharmacokinetic and pharmacodynamic evaluation of metronomic and conventional temozolomide dosing regimens

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23859

7 January 2021

based on heuristic

inferred from DOI database lookup

Marked inactivation of O6-alkylguanine-DNA alkyltransferase activity with protracted temozolomide schedules

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23859

7 January 2021

based on heuristic

inferred from DOI database lookup

Vinorelbine combined with a protracted course of temozolomide for recurrent brain metastases: a phase I trial.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23859

7 January 2021

based on heuristic

inferred from DOI database lookup

Current management of brain metastases, with a focus on systemic options

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23859

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment options for brain metastases in patients with non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23859

7 January 2021

based on heuristic

inferred from DOI database lookup

Optimizing therapy for patients with brain metastases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23859

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46362575&oldid=1966811006"